Company intelligence / Profile preview

Arbor Vita Corporation

Fremont, California, United States

Ownership: Private
Development stage: Other

Overview

Arbor Vita Corporation develops and commercializes rapid, proteomic-based diagnostics for infectious diseases (including COVID-19 and avian influenza) and cancers (notably cervical cancer via HPV detection). Their OncoE6™ Cervical Test is FDA-cleared for cervical cancer screening, and they offer same-day COVID-19 testing with CLIA-certified facilities. The company’s platform leverages PDZ domain proteins and proprietary monoclonal antibodies for highly sensitive, point-of-care tests applicable in both advanced and resource-limited settings.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Monoclonal antibodyDiagnosticProteinNucleic acid technology
Industry: Protein Biomarker Diagnostics

Partnerships

United States NavyYale University

Beyond the preview

Go deeper on Arbor Vita Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arbor Vita Corporation.

Explore the full profile